MedPath

Effect of Coenzyme Q10 Supplementation on Gestational Diabetes

Phase 3
Recruiting
Conditions
Gestational Diabetes.
Gestational diabetes mellitus NOS
Registration Number
IRCT20080910001233N4
Lead Sponsor
Rasht University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
60
Inclusion Criteria

Age between 40 and 18 years old
fasting plasma glucose (FBS) = 92 mg / dl
tolerance testing Oral glucose with 75 g glucose 1 hour (1-hOGTT) =180 mg / dl
Oral glucose tolerance test 75 g Glucose 2 hours (2-hOGTT) = 153 mg / dl
Individuals completing and delivering the informed consent form of the study.

Exclusion Criteria

The sudden separation of the placenta from the fetus
Preeclampsia
Eclampsia
Hypothyroidism
hyperthyroidism
History of any type of diabetes
smoking
Liver disease
kidney disease
Taking antibiotics
Taking glucocorticoids
Treated with insulin

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Blood sugar level. Timepoint: Before intervention, after intervention. Method of measurement: Colorimetric method.
Secondary Outcome Measures
NameTimeMethod
HDL-C. Timepoint: Before intervention, after intervention. Method of measurement: Colorimetric method.
© Copyright 2025. All Rights Reserved by MedPath